Fort Collins, Colorado, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The Epigenetics Market size was valued at USD 1.8 Billion in 2022 and is expected to reach a market size of USD 7.9 Billion by 2032 with a CAGR of 16.4%.
Cancer is a leading cause of death, and mortality rates are increasing. To combat this, many people are participating in cancer screening programs, and research institutes are studying epigenetics to develop drugs and vaccines for cancers with no effective treatment. By 2040, cancer cases per year are projected to reach 29.5 million, with 16.4 million deaths per year.
The growing elderly population is also a significant factor in market growth, as the global population of those aged 65 and older is set to double by 2050, causing an increase in neurological, cardiovascular, and infectious diseases. The body's immune system weakens with age, making it more vulnerable to infections.
The growing elderly population in Asia, particularly in countries like Japan, India, and China, is expected to drive market expansion. By 2050, it is estimated that 25% of the old-age population will be in Asia, creating a significant demand for epigenetics in the future, according to the National Institute of Health.
Request Sample Report:
https://datahorizzonresearch.com/request-sample-pdf/epigenetics-market-2297
Segmentation Overview:
The global epigenetics market has been segmented into product, technology, application, end-user, and region. Enzymes are crucial for epigenetics research and diagnostics and are used to modify DNA and proteins. Oncology is the largest segment of the epigenetics market due to the increase in cancer cases. The non-oncology segment includes metabolic, infectious, inflammatory, cardiovascular diseases, and other applications.
Buy This Research Report:
https://datahorizzonresearch.com/checkout-page/epigenetics-market-2297
Epigenetics Market Report Highlights:
- The global epigenetics market growth is anticipated to have a CAGR of 16.4% by 2032.
- The demand for epigenetics-based treatments is increasing due to their potential to prevent or treat chronic diseases like cancer and Alzheimer's.
- North America dominates the market due to its numerous research institutions and pharmaceutical companies, with FDA-approved epigenetics-based therapies driving growth.
- Some prominent players in the epigenetics market report include Bio-Rad, Illumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore, Quest Diagnostics, Abcam, New England Biolabs, PerkinElmer, Zymo Research, among others.
Industry Trends and Insights:
- Bio-Rad Laboratories has launched PTC Tempo Thermal Cyclers to support PCR applications.
- Illumina Inc. has introduced TruSight Oncology 500 ctDNA v2, a research assay for comprehensive genomic profiling of circulating tumor DNA.
Looking Exclusively For Region/Country Specific Report?
https://datahorizzonresearch.com/ask-for-customization/epigenetics-market-2297
OR
Ask For Discount
https://datahorizzonresearch.com/ask-for-discount/epigenetics-market-2297
Epigenetics Market Segmentation:
By Product: Reagents, Enzymes, Instruments, Kits
By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Others
By Application: Oncology, Non Oncology
By End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations
By Region: North America, Latin America, Europe, Asia Pacific, the Middle East and Africa.
About DataHorizzon Research:
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
Contact:
Mail: sales@datahorizzonresearch.com
Ph: +1-970-672-0390
Website: https://datahorizzonresearch.com/
Follow Us: LinkedIn
Recent Publications
Genetic Testing Market 2023 to 2032
Companion Diagnostics Market 2023 to 2032
Patient Engagement Market 2023 to 2032
Portable Medical Devices Market 2023 to 2032
Infusion Pumps Market 2023 to 2032
